BlackRock’s Standard BioTools LAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $6.79M | Sell |
8,254,443
-16,501,641
| -67% | -$15.6M | ﹤0.01% | 3834 |
|
|
2026
Q1 | $22.8M | Sell |
24,756,084
-759,849
| -3% | -$920K | ﹤0.01% | 3002 |
|
|
2025
Q4 | $32.7M | Buy |
25,515,933
+595,015
| +2% | +$799K | ﹤0.01% | 2792 |
|
|
2025
Q3 | $32.4M | Buy |
24,920,918
+96,158
| +0.4% | +$126K | ﹤0.01% | 2788 |
|
|
2025
Q2 | $29.8M | Buy |
24,824,760
+204,489
| +0.8% | +$227K | ﹤0.01% | 2788 |
|
|
2025
Q1 | $26.6M | Sell |
24,620,271
-237,579
| -1% | -$334K | ﹤0.01% | 2768 |
|
|
2024
Q4 | $43.5M | Buy |
24,857,850
+2,405,735
| +11% | +$4.48M | ﹤0.01% | 2539 |
|
|
2024
Q3 | $43.3M | Buy |
22,452,115
+699,108
| +3% | +$1.37M | ﹤0.01% | 2555 |
|
|
2024
Q2 | $38.5M | Buy |
21,753,007
+16,302,778
| +299% | +$39.8M | ﹤0.01% | 2575 |
|
|
2024
Q1 | $14.8M | Buy |
5,450,229
+3,840,621
| +239% | +$9.27M | ﹤0.01% | 3154 |
|
|
2023
Q4 | $3.56M | Buy |
1,609,608
+244,224
| +18% | +$521K | ﹤0.01% | 3830 |
|
|
2023
Q3 | $3.96M | Sell |
1,365,384
-72,060
| -5% | -$188K | ﹤0.01% | 3748 |
|
|
2023
Q2 | $2.77M | Buy |
1,437,444
+18,290
| +1% | +$36.1K | ﹤0.01% | 3919 |
|
|
2023
Q1 | $2.77M | Buy |
1,419,154
+11,783
| +0.8% | +$23.3K | ﹤0.01% | 3894 |
|
|
2022
Q4 | $1.65M | Sell |
1,407,371
-578,093
| -29% | -$712K | ﹤0.01% | 4215 |
|
|
2022
Q3 | $2.18M | Sell |
1,985,464
-31,746
| -2% | -$48K | ﹤0.01% | 4153 |
|
|
2022
Q2 | $3.23M | Sell |
2,017,210
-4,148,506
| -67% | -$10.3M | ﹤0.01% | 4016 |
|
|
2022
Q1 | $22.1M | Sell |
6,165,716
-85,514
| -1% | -$295K | ﹤0.01% | 3108 |
|
|
2021
Q4 | $24.5M | Sell |
6,251,230
-99,499
| -2% | -$466K | ﹤0.01% | 3160 |
|
|
2021
Q3 | $41.9M | Sell |
6,350,729
-13,207
| -0.2% | -$86.9K | ﹤0.01% | 2774 |
|
|
2021
Q2 | $39.2M | Buy |
6,363,936
+112,361
| +2% | +$601K | ﹤0.01% | 2855 |
|
|
2021
Q1 | $28.3M | Buy |
6,251,575
+673,616
| +12% | +$3.7M | ﹤0.01% | 2985 |
|
|
2020
Q4 | $33.5M | Buy |
5,577,959
+210,992
| +4% | +$1.39M | ﹤0.01% | 2722 |
|
|
2020
Q3 | $39.9M | Buy |
5,366,967
+132,980
| +3% | +$918K | ﹤0.01% | 2429 |
|
|
2020
Q2 | $21M | Sell |
5,233,987
-65,286
| -1% | -$227K | ﹤0.01% | 2770 |
|
|
2020
Q1 | $13.5M | Buy |
5,299,273
+8,952
| +0.2% | +$29.4K | ﹤0.01% | 2827 |
|
|
2019
Q4 | $18.4M | Buy |
5,290,321
+353,114
| +7% | +$1.24M | ﹤0.01% | 2927 |
|
|
2019
Q3 | $22.9M | Sell |
4,937,207
-6,091
| -0.1% | -$48K | ﹤0.01% | 2737 |
|
|
2019
Q2 | $60.9M | Buy |
4,943,298
+2,293,024
| +87% | +$29.2M | ﹤0.01% | 2217 |
|
|
2019
Q1 | $35.2M | Buy |
2,650,274
+510,396
| +24% | +$5.38M | ﹤0.01% | 2480 |
|
|
2018
Q4 | $18.4M | Buy |
2,139,878
+178,429
| +9% | +$1.39M | ﹤0.01% | 2761 |
|
|
2018
Q3 | $14.7M | Sell |
1,961,449
-38,832
| -2% | -$276K | ﹤0.01% | 3032 |
|
|
2018
Q2 | $11.9M | Sell |
2,000,281
-212,482
| -10% | -$1.21M | ﹤0.01% | 3145 |
|
|
2018
Q1 | $12.9M | Buy |
2,212,763
+27,881
| +1% | +$183K | ﹤0.01% | 2995 |
|
|
2017
Q4 | $12.9M | Buy |
2,184,882
+337,639
| +18% | +$1.85M | ﹤0.01% | 3020 |
|
|
2017
Q3 | $9.31M | Buy |
1,847,243
+11,428
| +0.6% | +$48K | ﹤0.01% | 3206 |
|
|
2017
Q2 | $7.42M | Buy |
1,835,815
+12,681
| +0.7% | +$60.1K | ﹤0.01% | 3325 |
|
|
2017
Q1 | $10.4M | Buy |
1,823,134
+1,821,017
| +86,019% | +$11.5M | ﹤0.01% | 3091 |
|
|
2016
Q4 | $15K | Sell |
2,117
-330
| -13% | -$2.07K | ﹤0.01% | 3311 |
|
|
2016
Q3 | $20K | Hold |
2,447
| – | – | ﹤0.01% | 3284 |
|
|
2016
Q2 | $23K | Buy |
2,447
+493
| +25% | +$4.63K | ﹤0.01% | 3228 |
|
|
2016
Q1 | $16K | Buy |
1,954
+1,341
| +219% | +$9.67K | ﹤0.01% | 2951 |
|
|
2015
Q4 | $7K | Hold |
613
| – | – | ﹤0.01% | 3041 |
|
|
2015
Q3 | $5K | Hold |
613
| – | – | ﹤0.01% | 3012 |
|
|
2015
Q2 | $15K | Sell |
613
-56
| -8% | -$1.77K | ﹤0.01% | 2543 |
|
|
2015
Q1 | $28K | Hold |
669
| – | – | ﹤0.01% | 2201 |
|
|
2014
Q4 | $23K | Hold |
669
| – | – | ﹤0.01% | 2294 |
|
|
2014
Q3 | $16K | Hold |
669
| – | – | ﹤0.01% | 2449 |
|
|
2014
Q2 | $20K | Buy |
669
+27
| +4% | +$865 | ﹤0.01% | 2377 |
|
|
2014
Q1 | $28K | Hold |
642
| – | – | ﹤0.01% | 2186 |
|
|
2013
Q4 | $25K | Sell |
642
-47
| -7% | -$1.38K | ﹤0.01% | 2255 |
|
|
2013
Q3 | $15K | Hold |
689
| – | – | ﹤0.01% | 2408 |
|
|
2013
Q2 | $12K | Buy |
+689
| New | +$12.1K | ﹤0.01% | 2547 |
|
Other funds holding LAB
CC
MCO
LFCM
HBWM
RA
BlackRock's LAB Position: Q2 2026 in Review
BlackRock reduced its Standard BioTools (LAB) stake by 67% in Q2 2026, selling an estimated $15.6M and leaving 8,254,443 shares worth $6.79M. The position accounts for ﹤0.01% of the portfolio, ranked #3834.
BlackRock first reported a position in LAB in Q2 2013 and has held it in 53 quarters since. The position peaked at $60.9M in Q2 2019. 143 funds tracked by Wall St. Rank hold LAB as of Q2 2026.
- BlackRock held 8,254,443 shares of Standard BioTools worth $6.79M as of Q2 2026.
- BlackRock sold 16,501,641 Standard BioTools shares in Q2 2026, an estimated $15.6M.
- Standard BioTools made up ﹤0.01% of BlackRock's portfolio in Q2 2026, its #3834 holding.
- BlackRock first reported a position in Standard BioTools in Q2 2013 and has held it in 53 quarters since.
- BlackRock's Standard BioTools position peaked at $60.9M in Q2 2019.
- 143 funds tracked by Wall St. Rank held Standard BioTools as of Q2 2026.
Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.